CEGEDIM SA (CGM.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:CGM • FR0000053506

10.4 EUR
-0.2 (-1.89%)
Last: Sep 3, 2025, 07:00 PM
Fundamental Rating

3

Overall CGM gets a fundamental rating of 3 out of 10. We evaluated CGM against 12 industry peers in the Health Care Technology industry. Both the profitability and financial health of CGM have multiple concerns. CGM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CGM had negative earnings in the past year.
  • In the past year CGM had a positive cash flow from operations.
  • In multiple years CGM reported negative net income over the last 5 years.
  • Each year in the past 5 years CGM had a positive operating cash flow.
CGM.PA Yearly Net Income VS EBIT VS OCF VS FCFCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • With a Return On Assets value of -1.49%, CGM perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • CGM's Return On Equity of -5.56% is in line compared to the rest of the industry. CGM outperforms 45.45% of its industry peers.
  • CGM's Return On Invested Capital of 4.46% is in line compared to the rest of the industry. CGM outperforms 45.45% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CGM is significantly below the industry average of 8.64%.
  • The last Return On Invested Capital (4.46%) for CGM is above the 3 year average (2.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.49%
ROE -5.56%
ROIC 4.46%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
CGM.PA Yearly ROA, ROE, ROICCGM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • CGM has a Operating Margin of 5.75%. This is comparable to the rest of the industry: CGM outperforms 45.45% of its industry peers.
  • CGM's Operating Margin has declined in the last couple of years.
  • CGM has a worse Gross Margin (20.07%) than 81.82% of its industry peers.
  • CGM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.75%
PM (TTM) N/A
GM 20.07%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
CGM.PA Yearly Profit, Operating, Gross MarginsCGM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CGM is still creating some value.
  • The number of shares outstanding for CGM has been increased compared to 1 year ago.
  • The number of shares outstanding for CGM has been reduced compared to 5 years ago.
  • CGM has a worse debt/assets ratio than last year.
CGM.PA Yearly Shares OutstandingCGM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CGM.PA Yearly Total Debt VS Total AssetsCGM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.27, we must say that CGM is in the distress zone and has some risk of bankruptcy.
  • CGM's Altman-Z score of 1.27 is in line compared to the rest of the industry. CGM outperforms 45.45% of its industry peers.
  • The Debt to FCF ratio of CGM is 27.31, which is on the high side as it means it would take CGM, 27.31 years of fcf income to pay off all of its debts.
  • CGM has a Debt to FCF ratio (27.31) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.14 is on the high side and indicates that CGM has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.14, CGM is doing worse than 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.31
Altman-Z 1.27
ROIC/WACC1.08
WACC4.14%
CGM.PA Yearly LT Debt VS Equity VS FCFCGM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • CGM has a Current Ratio of 0.99. This is a bad value and indicates that CGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CGM has a worse Current ratio (0.99) than 63.64% of its industry peers.
  • CGM has a Quick Ratio of 0.99. This is a bad value and indicates that CGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.97, CGM is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.97
CGM.PA Yearly Current Assets VS Current LiabilitesCGM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

  • CGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.97%.
  • The Revenue has been growing slightly by 6.25% in the past year.
  • Measured over the past years, CGM shows a small growth in Revenue. The Revenue has been growing by 5.38% on average per year.
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%

3.2 Future

  • CGM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.86% yearly.
  • The Revenue is expected to grow by 3.41% on average over the next years.
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CGM.PA Yearly Revenue VS EstimatesCGM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CGM.PA Yearly EPS VS EstimatesCGM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

  • CGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 9.28, which indicates a very decent valuation of CGM.
  • 90.91% of the companies in the same industry are more expensive than CGM, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CGM to the average of the S&P500 Index (25.64), we can say CGM is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.28
CGM.PA Price Earnings VS Forward Price EarningsCGM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CGM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CGM is valued cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.29
EV/EBITDA 3.23
CGM.PA Per share dataCGM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • CGM's earnings are expected to grow with 21.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.1%
EPS Next 3Y21.86%

More info and screens

0

5. Dividend

5.1 Amount

  • CGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEGEDIM SA

EPA:CGM (9/3/2025, 7:00:00 PM)

10.4

-0.2 (-1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A
Earnings (Next)09-25
Inst Owners17.29%
Inst Owner ChangeN/A
Ins Owners57.12%
Ins Owner ChangeN/A
Market Cap146.64M
Revenue(TTM)654.50M
Net Income(TTM)-14.71M
Analysts48.89
Price Target12.92 (24.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.56%
PT rev (3m)-7.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.49%
EPS NY rev (3m)-24.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.28
P/S 0.22
P/FCF 12.29
P/OCF 1.44
P/B 0.55
P/tB N/A
EV/EBITDA 3.23
EPS(TTM)-1.07
EYN/A
EPS(NY)1.12
Fwd EY10.78%
FCF(TTM)0.85
FCFY8.14%
OCF(TTM)7.22
OCFY69.45%
SpS46.42
BVpS18.75
TBVpS-11.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.49%
ROE -5.56%
ROCE 6.06%
ROIC 4.46%
ROICexc 4.84%
ROICexgc 19.22%
OM 5.75%
PM (TTM) N/A
GM 20.07%
FCFM 1.82%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score3
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.31
Debt/EBITDA 2.3
Cap/Depr 96.22%
Cap/Sales 13.74%
Interest Coverage 4.24
Cash Conversion 77.7%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.97
Altman-Z 1.27
F-Score3
WACC4.14%
ROIC/WACC1.08
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
EBIT growth 1Y79.81%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year278.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.81%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y4.01%
OCF growth 3Y2%
OCF growth 5Y28.33%

CEGEDIM SA / CGM.PA FAQ

What is the fundamental rating for CGM stock?

ChartMill assigns a fundamental rating of 3 / 10 to CGM.PA.


What is the valuation status of CEGEDIM SA (CGM.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CEGEDIM SA (CGM.PA). This can be considered as Fairly Valued.


What is the profitability of CGM stock?

CEGEDIM SA (CGM.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for CGM stock?

The dividend rating of CEGEDIM SA (CGM.PA) is 0 / 10 and the dividend payout ratio is 0%.